Medical cannabis production in Australia is hinging upon generous grants and donations from some of the nation’s most wealthy.
Brussels saw new lobby groups pop up; France planned to launch a new medical cannabis program for 3,000 patients; and Luxembourg was going to unveil a plan to make recreational cannabis legal.
The boy who became the figurehead of medical cannabis policy changes in the United Kingdom is set to receive his first bottle of cannabis-derived medicine on the two-year anniversary of the reforms.
The French government published a long-awaited decree this week detailing how a limited medical cannabis experiment will be carried out.
As the government tries desperately to salvage a shattered economy, an unlikely but profitable lifeline presents itself: medical cannabis.
Up to half of people in the UK are unaware that medical cannabis is legal in the UK, according to an ongoing poll by Canex. Out of 13,254 respondents, 46% revealed that they were unaware of the 2018 rescheduling which made medical cannabis legal in the UK.
There is no European plan to address in the short-term the regulatory barriers for the use of cannabis for medicinal purposes, the Council presidency of the EU and the European Commission have confirmed to EURACTIV.
Patients enrolled in the state’s medical cannabis access program will be able to purchase cannabis-infused edible products from licensed dispensaries for the first time, under legislation recently signed into law by Democratic Gov. David Ige.
A number of mothers, each with a severely epileptic child, are today holding a vigil outside the offices of the Department of Health & Social Care, the London headquarters of NHSE, the Scottish Parliament, and the Welsh Assembly.
From 1 November this year, a new cannabis exemption card will be available to protect medicinal cannabis patients from arrest and legal prosecution in the UK.